Growth in children with acute lymphoblastic leukemia during treatment

Laura Collins, Lee Ann Zarzabal, Trishana Nayiager, Brad H. Pollock, Ronald D. Barr

Research output: Contribution to journalArticlepeer-review

27 Scopus citations


Obesity is increasingly prevalent in affluent societies and portends considerable morbidity. This is especially true in children with acute lymphoblastic leukemia (ALL) in whom the metabolic syndrome may begin during therapy, demanding clarification of the trajectory of weight gain so that effective interventions may be developed. In this retrospective study of body mass index from a single institution over a 20-year period, almost 15% of children with ALL were at risk of overweight or frankly overweight (body mass index > 85th centile) at diagnosis. This proportion increased steadily, reaching 40% at the end of treatment. Strategies to limit weight gain will have to be instituted early in the management of children with ALL, and will probably have to be maintained throughout and after the completion of active treatment.

Original languageEnglish (US)
Pages (from-to)e304-e307
JournalJournal of Pediatric Hematology/Oncology
Issue number8
StatePublished - 2010


  • Children
  • Growth
  • Leukemia

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology


Dive into the research topics of 'Growth in children with acute lymphoblastic leukemia during treatment'. Together they form a unique fingerprint.

Cite this